PL201997A1 - Sposob wytwarzania nowych pochodnych aminopropanolu - Google Patents

Sposob wytwarzania nowych pochodnych aminopropanolu

Info

Publication number
PL201997A1
PL201997A1 PL20199777A PL20199777A PL201997A1 PL 201997 A1 PL201997 A1 PL 201997A1 PL 20199777 A PL20199777 A PL 20199777A PL 20199777 A PL20199777 A PL 20199777A PL 201997 A1 PL201997 A1 PL 201997A1
Authority
PL
Poland
Prior art keywords
aminopropanol
new derivatives
making new
making
derivatives
Prior art date
Application number
PL20199777A
Other languages
English (en)
Other versions
PL110782B1 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762651574 external-priority patent/DE2651574A1/de
Priority claimed from DE19772737630 external-priority patent/DE2737630A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of PL201997A1 publication Critical patent/PL201997A1/pl
Publication of PL110782B1 publication Critical patent/PL110782B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL1977201997A 1976-11-12 1977-11-09 Method of producing new derivatives of aminopropanol PL110782B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762651574 DE2651574A1 (de) 1976-11-12 1976-11-12 Ein neues aminopropanol-derivat und verfahren zu dessen herstellung
DE19772737630 DE2737630A1 (de) 1977-08-20 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
PL201997A1 true PL201997A1 (pl) 1979-03-12
PL110782B1 PL110782B1 (en) 1980-07-31

Family

ID=25771134

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1977201997A PL110782B1 (en) 1976-11-12 1977-11-09 Method of producing new derivatives of aminopropanol
PL1977213346A PL112683B1 (en) 1976-11-12 1977-11-09 Process for preparing novel derivatives of aminopropanol

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1977213346A PL112683B1 (en) 1976-11-12 1977-11-09 Process for preparing novel derivatives of aminopropanol

Country Status (23)

Country Link
US (1) US4146630A (pl)
JP (1) JPS5363385A (pl)
AR (3) AR218643A1 (pl)
AT (1) AT361476B (pl)
AU (1) AU510284B2 (pl)
CA (1) CA1086740A (pl)
CH (3) CH636099A5 (pl)
CS (1) CS228106B2 (pl)
DD (1) DD133801A5 (pl)
DK (1) DK500677A (pl)
ES (2) ES472746A1 (pl)
FI (1) FI62077C (pl)
FR (1) FR2370744A1 (pl)
GB (1) GB1541547A (pl)
HU (1) HU177410B (pl)
IL (1) IL53323A (pl)
IT (1) IT1087490B (pl)
LU (1) LU78498A1 (pl)
NL (1) NL7712220A (pl)
PL (2) PL110782B1 (pl)
SE (1) SE7712720L (pl)
SU (2) SU826955A3 (pl)
YU (3) YU266477A (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
US4495352A (en) * 1979-02-13 1985-01-22 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
DE2905876A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2922084A1 (de) * 1979-05-31 1980-12-11 Boehringer Mannheim Gmbh Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3584560D1 (de) * 1984-04-09 1991-12-05 Du Pont Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
WO2010059390A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Modulators of serotonin receptor
WO2010059393A1 (en) * 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Serotonin receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925429A (en) * 1960-04-01 1963-05-08 Irwin Neisler & Co Indole derivatives
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
BE794333A (fr) * 1972-01-20 1973-07-19 Wyeth John & Brother Ltd Composes heterocycliques azotes therapeutiques
JPS48103590A (pl) * 1972-04-13 1973-12-25
JPS6024100B2 (ja) * 1975-02-11 1985-06-11 ベーリンガー・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング アミノプロパノ−ル−誘導体の製法
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Also Published As

Publication number Publication date
FR2370744A1 (fr) 1978-06-09
CS228106B2 (en) 1984-05-14
IL53323A0 (en) 1978-01-31
LU78498A1 (pl) 1979-02-02
JPS6341910B2 (pl) 1988-08-19
CH639086A5 (de) 1983-10-31
DD133801A5 (de) 1979-01-24
SE7712720L (sv) 1978-05-13
AR218643A1 (es) 1980-06-30
ES472747A1 (es) 1979-02-16
CA1086740A (en) 1980-09-30
AU510284B2 (en) 1980-06-19
IL53323A (en) 1981-12-31
CH643554A5 (de) 1984-06-15
IT1087490B (it) 1985-06-04
HU177410B (en) 1981-10-28
FI773346A7 (fi) 1978-05-13
FI62077B (fi) 1982-07-30
AT361476B (de) 1981-03-10
SU826955A3 (ru) 1981-04-30
YU128983A (en) 1984-04-30
YU266477A (en) 1984-02-29
GB1541547A (en) 1979-03-07
CH636099A5 (de) 1983-05-13
DK500677A (da) 1978-05-13
AR221868A1 (es) 1981-03-31
AU3046677A (en) 1979-05-17
FI62077C (fi) 1982-11-10
FR2370744B1 (pl) 1981-06-12
NL7712220A (nl) 1978-05-17
SU890975A3 (ru) 1981-12-15
JPS5363385A (en) 1978-06-06
PL110782B1 (en) 1980-07-31
AR221081A1 (es) 1980-12-30
US4146630A (en) 1979-03-27
ATA808277A (de) 1980-08-15
ES472746A1 (es) 1979-02-16
YU128883A (en) 1984-04-30
PL112683B1 (en) 1980-10-31

Similar Documents

Publication Publication Date Title
PL201286A1 (pl) Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow
PL201997A1 (pl) Sposob wytwarzania nowych pochodnych aminopropanolu
PL215008A1 (pl) Sposob wytwarzania pochodnych piranonu-3
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL200685A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL199298A1 (pl) Sposob wytwarzania 2-bromo-6-fluoro-n-2-imidazolidynylideno-benzaminy
PL193183A1 (pl) Sposob wytwarzania nowych pochodnych 11-dezoksy-16-arylo-omega-tetranorprostaglandyny
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL199633A1 (pl) Sposob wytwarzania 5-m-toliloksyuracylu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL197045A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL202660A1 (pl) Sposob wytwarzania nowych pochodnych spirooksazolidynodionu
PL104866B1 (pl) Sposob wytwarzania nowych pirydobenzodwuazepinonow
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL201161A1 (pl) Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu
PL209049A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL196061A1 (pl) Sposob wytwarzania nowych pochodnych indolizyny
PL197703A1 (pl) Sposob wytwarzania nowych pochodnych indazolu

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20090614